600998 九州通
已收盘 05-08 15:00:00
资讯
新帖
简况
九州通(600998.SH)子公司通过药品GMP符合性检查
智通财经 · 05-06 17:02
九州通(600998.SH)子公司通过药品GMP符合性检查
每周股票复盘：九州通（600998）股东户数增13.92%，净利降24.41%
证券之星 · 05-02
每周股票复盘：九州通（600998）股东户数增13.92%，净利降24.41%
图解九州通年报：第四季度单季净利润同比下降65.56%
证券之星 · 04-28
图解九州通年报：第四季度单季净利润同比下降65.56%
每周股票复盘：九州通（600998）子公司药品上市申请获国家药监局受理
证券之星 · 04-26
每周股票复盘：九州通（600998）子公司药品上市申请获国家药监局受理
九州通（600998）披露子公司盐酸氮䓬斯汀鼻喷雾剂上市申请获国家药监局受理，4月21日股价上涨1.32%
证券之星 · 04-21
九州通（600998）披露子公司盐酸氮䓬斯汀鼻喷雾剂上市申请获国家药监局受理，4月21日股价上涨1.32%
每周股票复盘：九州通（600998）为56家子公司担保27.97亿元
证券之星 · 04-19
每周股票复盘：九州通（600998）为56家子公司担保27.97亿元
九州通（600998）披露为子公司提供担保的进展公告，4月15日股价上涨1.69%
证券之星 · 04-15
九州通（600998）披露为子公司提供担保的进展公告，4月15日股价上涨1.69%
九州通（600998）披露获准注册40亿元资产支持票据，4月3日股价下跌1.86%
证券之星 · 04-03
九州通（600998）披露获准注册40亿元资产支持票据，4月3日股价下跌1.86%
每周股票复盘：九州通（600998）参投企业凯乐士科技港股上市
证券之星 · 03-29
每周股票复盘：九州通（600998）参投企业凯乐士科技港股上市
九州通最新公告：控股子公司取得经颅重复磁刺激仪医疗器械注册证
证券之星 · 03-24
九州通最新公告：控股子公司取得经颅重复磁刺激仪医疗器械注册证
每周股票复盘：九州通（600998）担保总额达307.36亿元占净资产112.82%
证券之星 · 03-22
每周股票复盘：九州通（600998）担保总额达307.36亿元占净资产112.82%
九州通（600998）披露为子公司提供担保的进展公告，3月17日股价上涨0.19%
证券之星 · 03-17
九州通（600998）披露为子公司提供担保的进展公告，3月17日股价上涨0.19%
每周股票复盘：九州通（600998）发行3亿元科创债利率1.8%
证券之星 · 03-15
每周股票复盘：九州通（600998）发行3亿元科创债利率1.8%
九州通新注册《九小递平台V1.0》等2个项目的软件著作权
证券之星 · 03-15
九州通新注册《九小递平台V1.0》等2个项目的软件著作权
广药集团与九州通集团业务交流会召开
人民财讯 · 03-14
广药集团与九州通集团业务交流会召开
九州通（600998）披露2026年度第二期科技创新债券发行结果，3月11日股价下跌0.19%
证券之星 · 03-11
九州通（600998）披露2026年度第二期科技创新债券发行结果，3月11日股价下跌0.19%
九州通：数智物流助药速达
证券日报 · 03-03
九州通：数智物流助药速达
九州通（600998）披露为子公司提供担保的进展公告，2月24日股价上涨1.36%
证券之星 · 02-24
九州通（600998）披露为子公司提供担保的进展公告，2月24日股价上涨1.36%
每周股票复盘：九州通（600998）为36家子公司担保25.89亿元
证券之星 · 02-15
每周股票复盘：九州通（600998）为36家子公司担保25.89亿元
九州通（600998）股东上海弘康实业投资有限公司质押1600万股，占总股本0.32%
证券之星 · 02-05
九州通（600998）股东上海弘康实业投资有限公司质押1600万股，占总股本0.32%
加载更多
公司概况
公司名称：
九州通医药集团股份有限公司
所属行业：
批发业
上市日期：
2010-11-02
主营业务：
九州通医药集团股份有限公司的主营业务是医药流通、医药新零售、医药工业、医药CSO业务。公司的主要产品是数字化医药分销、供应链业务、总代品牌推广业务（CSO）、医药工业自产及OEM业务、新零售与万店加盟业务（C端）、医疗健康（C端）、技术增值服务、数字物流与供应链解决方案。公司先后荣获中国上市公司协会2024年度“上市公司投资者关系管理最佳实践奖”、证券时报“中国上市公司投资者关系管理天马奖”、中国证券报金牛奖“2024年度金牛上市公司分红回报奖”和“2024年度金牛最具价值投资奖”等荣誉。
发行价格：
13.00
{"stockData":{"symbol":"600998","market":"SH","secType":"STK","nameCN":"九州通","latestPrice":5.05,"timestamp":1778223601000,"preClose":5.06,"halted":0,"volume":30153829,"delay":0,"changeRate":-0.002,"floatShares":5042000000,"shares":5042000000,"eps":0.4003,"marketStatus":"已收盘","change":-0.01,"latestTime":"05-08 15:00:00","open":5.05,"high":5.09,"low":5.02,"amount":152000000,"amplitude":0.0138,"askPrice":5.06,"askSize":4968,"bidPrice":5.05,"bidSize":975,"shortable":0,"etf":0,"ttmEps":0.4003,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778463000000},"marketStatusCode":5,"adr":0,"adjPreClose":5.06,"symbolType":"stock","openAndCloseTimeList":[[1778203800000,1778211000000],[1778216400000,1778223600000]],"highLimit":5.57,"lowLimit":4.55,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":5042470234,"isCdr":false,"pbRate":0.93,"roa":"--","peRate":12.615538,"roe":"2.62%","epsLYR":0.44,"committee":0.275266,"marketValue":25464000000,"turnoverRate":0.006,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-05-11。","floatMarketCap":25464000000},"requestUrl":"/m/hq/s/600998","defaultTab":"news","newsList":[{"id":"2633584188","title":"九州通(600998.SH)子公司通过药品GMP符合性检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2633584188","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633584188?lang=zh_cn&edition=full","pubTime":"2026-05-06 17:02","pubTimestamp":1778058136,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九州通(600998.SH)发布公告，近日，公司子公司北京京丰制药(山东)有限公司(简称“山东京丰”)收到山东省药品监督管理局核准签发的《药品GMP符合性检查告知书》(编号：GMP2026081)。公司积极拓展医药工业自产及OEM业务，持续强化药品研发及生产能力，打造具有核心竞争力的产品矩阵，2025年医药工业自产及OEM业务实现销售收入33.33亿元，同比增长10.81%。山东京丰本次片剂生产线顺利通过GMP现场符合性检查，表明公司产品生产质量管理符合药品GMP要求，有利于公司继续保持稳定的产品质量和持续稳定的生产能力，以满足相关药品的市场需求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438547.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0077","BK0097","600998","BK0196","BK0183","BK0012","BK0146","BK0201","BK0039","BK0187","BK0028","BK0188","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632444326","title":"每周股票复盘：九州通（600998）股东户数增13.92%，净利降24.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632444326","media":"证券之星","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632444326?lang=zh_cn&edition=full","pubTime":"2026-05-02 03:20","pubTimestamp":1777663222,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，九州通报收于5.17元，较上周的5.41元下跌4.44%。本周关注点股本股东变化：股东户数较上年末增加13.92%，达5.84万户业绩披露要点：归母净利润7.33亿元，同比下降24.41%股本股东变化股东户数变动截至2026年3月31日，九州通股东户数为5.84万户，较2025年12月31日增加7135户，增幅13.92%。业绩披露要点财务报告2026年一季度，九州通实现主营收入447.83亿元，同比增长6.58%；归母净利润7.33亿元，同比下降24.41%；扣非净利润5.43亿元，同比增长7.12%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200000695.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK0196","BK0097","BK0188","BK0146","BK0028","BK0077","BK0250","BK0187","BK0039","BK0201","BK0012","600998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630316094","title":"图解九州通年报：第四季度单季净利润同比下降65.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630316094","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630316094?lang=zh_cn&edition=full","pubTime":"2026-04-28 00:54","pubTimestamp":1777308873,"startTime":"0","endTime":"0","summary":"证券之星消息，九州通2025年年报显示，当年度公司主营收入1613.9亿元，同比上升6.31%；归母净利润22.55亿元，同比下降10.07%；扣非净利润17.48亿元，同比下降3.63%；其中2025年第四季度，公司单季度主营收入420.63亿元，同比上升9.6%；单季度归母净利润2.79亿元，同比下降65.56%；单季度扣非净利润2.78亿元，同比上升50.99%；负债率68.33%，投资收益10.0亿元，财务费用9.42亿元，毛利率7.78%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800002515.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630017428","title":"每周股票复盘：九州通（600998）子公司药品上市申请获国家药监局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2630017428","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630017428?lang=zh_cn&edition=full","pubTime":"2026-04-26 03:00","pubTimestamp":1777143634,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘，九州通报收于5.41元，较上周的5.26元上涨2.85%。本周，九州通4月24日盘中最高价报5.48元。本周关注点公司公告汇总：控股子公司盐酸氮斯汀鼻喷雾剂上市申请获国家药监局受理。本次申请事项为境内生产药品注册上市许可，受理号为CYHS2600898。该药品注册申请已获受理，后续还需经过审评、审批等环节，存在不确定性，短期内不会对公司经营业绩产生影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600001144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","BK0183","600998","BK0077","BK0146","BK0097","BK0012","BK0187","BK0039","BK0201","BK0250","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629030058","title":"九州通（600998）披露子公司盐酸氮䓬斯汀鼻喷雾剂上市申请获国家药监局受理，4月21日股价上涨1.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629030058","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629030058?lang=zh_cn&edition=full","pubTime":"2026-04-21 22:30","pubTimestamp":1776781816,"startTime":"0","endTime":"0","summary":"截至2026年4月21日收盘，九州通报收于5.38元，较前一交易日上涨1.32%，最新总市值为271.28亿元。该股当日开盘5.3元，最高5.39元，最低5.29元，成交额达1.95亿元，换手率为0.72%。近日，九州通医药集团股份有限公司控股子公司北京京丰制药集团有限公司收到国家药品监督管理局签发的盐酸氮斯汀鼻喷雾剂上市申请《受理通知书》。本次申请事项为境内生产药品注册上市许可，受理号为CYHS2600898。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042100053652.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0187","BK0039","BK0077","BK0196","BK0183","BK0250","BK0028","600998","BK0146","BK0097","BK0188","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628807759","title":"每周股票复盘：九州通（600998）为56家子公司担保27.97亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2628807759","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628807759?lang=zh_cn&edition=full","pubTime":"2026-04-19 02:19","pubTimestamp":1776536346,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘，九州通报收于5.26元，较上周的5.36元下跌1.87%。本周，九州通4月15日盘中最高价报5.43元。九州通当前最新总市值265.23亿元，在医药商业板块市值排名3/32，在两市A股市值排名824/5198。本周关注点公司公告汇总：九州通为56家子公司提供合计279,670.00万元担保。公司公告汇总：截至2026年3月31日，公司对外担保总额达3,057,968.62万元。公司董事会认为担保风险可控，符合子公司经营需要。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900000749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0250","BK0097","BK0039","BK0183","BK0187","BK0196","600998","BK0012","BK0188","BK0146","BK0077","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627223870","title":"九州通（600998）披露为子公司提供担保的进展公告，4月15日股价上涨1.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627223870","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627223870?lang=zh_cn&edition=full","pubTime":"2026-04-15 22:22","pubTimestamp":1776262973,"startTime":"0","endTime":"0","summary":"截至2026年4月15日收盘，九州通报收于5.4元，较前一交易日上涨1.69%，最新总市值为272.29亿元。近日，九州通医药集团股份有限公司发布《关于为子公司提供担保的进展公告》。公告显示，公司为河南九州通医药有限公司、江苏九州通医药有限公司等56家子公司提供合计279,670.00万元的担保，均为对控股子公司及其下属企业的担保。截至2026年3月31日，公司对外担保总额为3,057,968.62万元，占最近一期经审计净资产的112.25%，无逾期担保。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500043184.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600998","BK0012","BK0077","BK0146","BK0250","BK0201","BK0188","BK0039","BK0196","BK0183","BK0097","BK0028","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624366871","title":"九州通（600998）披露获准注册40亿元资产支持票据，4月3日股价下跌1.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624366871","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624366871?lang=zh_cn&edition=full","pubTime":"2026-04-03 22:11","pubTimestamp":1775225477,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，九州通报收于5.28元，较前一交易日下跌1.86%，最新总市值为266.24亿元。九州通医药集团股份有限公司于2026年4月3日披露公告，公司近日收到中国银行间市场交易商协会签发的《接受注册通知书》，同意公司资产支持票据注册，注册金额为40亿元。首期发行应在注册后6个月内完成，后续发行需向交易商协会备案。发行完成后，公司将通过交易商协会认可的途径披露发行结果。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300043298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0028","BK0196","BK0201","BK0012","BK0146","BK0077","BK0183","BK0097","BK0187","BK0188","BK0039","600998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623222380","title":"每周股票复盘：九州通（600998）参投企业凯乐士科技港股上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2623222380","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623222380?lang=zh_cn&edition=full","pubTime":"2026-03-29 02:39","pubTimestamp":1774723149,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，九州通报收于5.09元，较上周的5.14元下跌0.97%。九州通医药集团股份有限公司参股公司浙江凯乐士科技集团股份有限公司于2026年3月24日在香港联合交易所主板挂牌上市，股票代码02729.HK，发行价格16.66港元/股，公开发行新股36,798,000股。九州通对凯乐士科技的投资成本为2,660.00万元，截至2025年12月31日账面价值为13,981.32万元，占公司最近一期经审计净资产的0.51%。凯乐士科技上市后，九州通持股比例为3.6511%，股票禁售期为12个月。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032900000488.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600998","BK0012","BK0077","BK0146","BK0250","BK0201","BK0188","BK0039","BK0196","BK0183","BK0097","02729","BK0028","BK0187"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2621068031","title":"九州通最新公告：控股子公司取得经颅重复磁刺激仪医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2621068031","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621068031?lang=zh_cn&edition=full","pubTime":"2026-03-24 17:39","pubTimestamp":1774345190,"startTime":"0","endTime":"0","summary":"九州通(600998.SH)公告称，公司控股子公司武汉柯尼兹医疗科技有限公司近日获得湖北省药监局核准签发的“经颅重复磁刺激仪”医疗器械注册证(编号：鄂械注准20262096046)，有效期至2031年3月17日，适用于3岁以上儿童及成人缺血性脑血管病、脑损伤性疾病的辅助治疗。该产品注册证的取得有助于丰富公司医疗器械产品线，推动“新产品”战略落地，但实际销售受行业政策、市场需求等因素影响，未来业绩贡献存在不确定性。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400030077.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0039","BK0028","BK0188","BK1583","09996","BK1222","BK0146","159883","600998","09997","BK0250","BK1574","BK0183","BK0196","BK0012","BK0097","BK0187","BK0077","BK1100","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621464799","title":"每周股票复盘：九州通（600998）担保总额达307.36亿元占净资产112.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621464799","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621464799?lang=zh_cn&edition=full","pubTime":"2026-03-22 03:04","pubTimestamp":1774119853,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，九州通报收于5.14元，较上周的5.31元下跌3.2%。本周，九州通3月17日盘中最高价报5.4元。九州通当前最新总市值259.18亿元，在医药商业板块市值排名3/32，在两市A股市值排名795/5190。截至2026年2月28日，公司对外担保总额为3,073,562.62万元，占最近一期经审计净资产的112.82%。担保方式为连带责任保证，部分担保设有反担保。被担保对象均为控股子公司及其下属企业，公司拥有控制权，担保风险可控。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032200000836.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0187","BK0039","BK0077","BK0196","BK0183","BK0250","BK0028","600998","BK0146","BK0097","BK0188","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620147379","title":"九州通（600998）披露为子公司提供担保的进展公告，3月17日股价上涨0.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620147379","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620147379?lang=zh_cn&edition=full","pubTime":"2026-03-17 22:26","pubTimestamp":1773757580,"startTime":"0","endTime":"0","summary":"截至2026年3月17日收盘，九州通报收于5.33元，较前一交易日上涨0.19%，最新总市值为268.76亿元。近日，九州通医药集团股份有限公司发布《关于为子公司提供担保的进展公告》。截至2026年2月28日，公司对外担保总额为3,073,562.62万元，占最近一期经审计净资产的112.82%。被担保对象均为控股子公司及其下属企业，公司拥有控制权，担保风险可控。公司无逾期担保。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031700042098.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600998","BK0012","BK0077","BK0146","BK0250","BK0201","BK0188","BK0039","BK0196","BK0183","BK0097","BK0028","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619966120","title":"每周股票复盘：九州通（600998）发行3亿元科创债利率1.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619966120","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619966120?lang=zh_cn&edition=full","pubTime":"2026-03-15 02:08","pubTimestamp":1773511695,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘，九州通报收于5.31元，较上周的5.26元上涨0.95%。本周，九州通3月13日盘中最高价报5.36元。九州通当前最新总市值267.76亿元，在医药商业板块市值排名3/32，在两市A股市值排名806/5190。本周关注点来自公司公告汇总：九州通完成发行3亿元科技创新债券，票面利率1.8%，期限3年。本期债券主承销商包括中信银行、招商银行等五家银行。自2025年12月17日获准注册30亿元额度以来，公司中期票据累计发行余额为3亿元，尚未兑付。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031500000512.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600998","159115","BK0183","BK0187","BK0146","BK0201","BK0028","BK0188","ZFmain","ZTmain","ZNmain","UBmain","BK0097","ZBmain","BK0250","BK0012","BK0039","TNmain","BK0077","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619012087","title":"九州通新注册《九小递平台V1.0》等2个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2619012087","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619012087?lang=zh_cn&edition=full","pubTime":"2026-03-15 01:49","pubTimestamp":1773510551,"startTime":"0","endTime":"0","summary":"证券之星消息，近日九州通新注册了2个项目的软件著作权，包括《九小递平台V1.0》、《九小菜平台V1.0》等。今年以来九州通新注册软件著作权2个，较去年同期减少了33.33%。结合公司2025年中报财务数据，2025上半年公司在研发方面投入了6679.03万元，同比减0.08%。通过天眼查大数据分析，九州通医药集团股份有限公司共对外投资了81家企业，参与招投标项目1412次；财产线索方面有商标信息1158条，专利信息30条，著作权信息90条；此外企业还拥有行政许可45个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031500000348.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0196","BK0188","BK0012","BK0028","600998","BK0077","BK0097","BK0187","BK0250","BK0183","BK0039","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619124459","title":"广药集团与九州通集团业务交流会召开","url":"https://stock-news.laohu8.com/highlight/detail?id=2619124459","media":"人民财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619124459?lang=zh_cn&edition=full","pubTime":"2026-03-14 22:49","pubTimestamp":1773499784,"startTime":"0","endTime":"0","summary":"【广药集团与九州通集团业务交流会召开】3月13日，广药集团与九州通医药集团股份有限公司（简称 “九州通集团”）召开业务交流会。这次会议是自2025年签署战略合作协议以来广药集团与九州通集团的又一次深度对接。未来，双方将携手并进，深化产品经销、基地建设、物流协同等多方面的战略合作，持续拓宽新场景、新领域，以务实行动助力健康中国建设。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603143672288666.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0097","600998","BK0146","BK0196","BK0012","BK0039","BK0183","BK0188","BK0028","BK0201","BK0187","BK0250","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618925885","title":"九州通（600998）披露2026年度第二期科技创新债券发行结果，3月11日股价下跌0.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618925885","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618925885?lang=zh_cn&edition=full","pubTime":"2026-03-11 22:16","pubTimestamp":1773238577,"startTime":"0","endTime":"0","summary":"截至2026年3月11日收盘，九州通报收于5.32元，较前一交易日下跌0.19%，最新总市值为268.26亿元。近日，九州通医药集团股份有限公司披露《关于2026年度第二期科技创新债券发行结果的公告》。公告显示，公司于2026年3月10日完成发行2026年度第二期科技创新债券，发行金额为3亿元，票面利率1.8%，期限3年，起息日为2026年3月11日，兑付日为2029年3月11日。自2025年12月17日获准注册30亿元额度以来，公司中期票据累计发行余额为3亿元，尚未兑付。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031100039350.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0250","BK0097","BK0039","BK0183","BK0187","BK0196","600998","BK0012","BK0188","BK0146","BK0077","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616367562","title":"九州通：数智物流助药速达","url":"https://stock-news.laohu8.com/highlight/detail?id=2616367562","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616367562?lang=zh_cn&edition=full","pubTime":"2026-03-03 00:36","pubTimestamp":1772469360,"startTime":"0","endTime":"0","summary":" 清晨的九州通医药集团股份有限公司现代医药物流基地内，数智化物流系统正在高效运转，智能仓储正自动完成药品的扫码、分拣和打包等工作，全程数据实时同步。凭借全国一体化智慧物流网络，九州通将药品精准、稳定、安全地送达各级医疗机构与零售终端，以数智化能力保障医药供应链高效畅通。 在此背景下，九州通以数智化物流技术与覆盖全国的物流网络，破解了行业痛点。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hyyj/2026-03-03/doc-inhprmyc1176208.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hyyj/2026-03-03/doc-inhprmyc1176208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0187","600998","BK0039","BK0097","BK0250","BK0196","BK0201","BK0183","BK0188","BK0077","BK0012","BK0146","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613293792","title":"九州通（600998）披露为子公司提供担保的进展公告，2月24日股价上涨1.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613293792","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613293792?lang=zh_cn&edition=full","pubTime":"2026-02-24 18:20","pubTimestamp":1771928448,"startTime":"0","endTime":"0","summary":"截至2026年2月24日收盘，九州通报收于5.22元，较前一交易日上涨1.36%，最新总市值为263.22亿元。九州通近日发布《关于为子公司提供担保的进展公告》。公告显示，公司为广东九州通、安徽九州通等36家子公司提供合计258,900.00万元的担保，均为前期预计额度内的担保，且均设有反担保。截至2026年1月31日，公司对外担保总额为3,028,972.62万元，占最近一期经审计净资产的111.18%，其中对资产负债率超过70%的子公司提供担保229,600.00万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400036190.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0039","BK0201","600998","BK0250","BK0097","BK0012","BK0183","BK0028","BK0187","BK0188","BK0196","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611145538","title":"每周股票复盘：九州通（600998）为36家子公司担保25.89亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611145538","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611145538?lang=zh_cn&edition=full","pubTime":"2026-02-15 02:04","pubTimestamp":1771092255,"startTime":"0","endTime":"0","summary":"截至2026年2月13日收盘，九州通报收于5.15元，较上周的5.22元下跌1.34%。本周，九州通2月11日盘中最高价报5.29元。本周关注点公司公告汇总：九州通为36家子公司提供合计258,900.00万元担保。公司公告汇总：截至2026年1月31日，公司对外担保总额达3,028,972.62万元。公司公告汇总九州通医药集团股份有限公司为广东九州通、安徽九州通等36家子公司提供合计258,900.00万元的担保，均为前期预计额度内的担保，且均设有反担保。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021500000604.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0187","BK0039","BK0077","BK0196","BK0183","BK0250","BK0028","600998","BK0146","BK0097","BK0188","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609140375","title":"九州通（600998）股东上海弘康实业投资有限公司质押1600万股，占总股本0.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609140375","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609140375?lang=zh_cn&edition=full","pubTime":"2026-02-05 18:31","pubTimestamp":1770287466,"startTime":"0","endTime":"0","summary":"证券之星消息，九州通2月5日公开信息显示，股东上海弘康实业投资有限公司向汉口银行股份有限公司汉阳支行合计质押1600.0万股，占总股本0.32%。九州通主营业务：涵盖医药流通、医药新零售、医药工业、医药CSO等业态,包括数字化医药分销与供应链业务、总代品牌推广业务、医药工业自产及OEM业务、新零售与万店加盟业务(C端)、医疗健康(C端)与技术增值服务、数字物流技术与供应链解决方案六大方面。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500032104.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0039","BK0201","600998","BK0250","BK0097","BK0012","BK0183","BK0028","BK0187","BK0188","BK0196","BK0146"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1778265307904,"stockEarnings":[{"period":"1week","weight":-0.0232},{"period":"1month","weight":-0.0665},{"period":"3month","weight":-0.0326},{"period":"6month","weight":-0.0137},{"period":"1year","weight":0.0086},{"period":"ytd","weight":-0.0137}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0463},{"period":"3month","weight":0.0281},{"period":"6month","weight":0.0456},{"period":"1year","weight":0.247},{"period":"ytd","weight":0.0532}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"九州通医药集团股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"58392人(较上一季度增加13.92%)","perCapita":"86355股","listingDate":"2010-11-02","address":"湖北省武汉市汉阳区龙兴西街5号","registeredCapital":"504247万元","survey":" 九州通医药集团股份有限公司的主营业务是医药流通、医药新零售、医药工业、医药CSO业务。公司的主要产品是数字化医药分销、供应链业务、总代品牌推广业务（CSO）、医药工业自产及OEM业务、新零售与万店加盟业务（C端）、医疗健康（C端）、技术增值服务、数字物流与供应链解决方案。公司先后荣获中国上市公司协会2024年度“上市公司投资者关系管理最佳实践奖”、证券时报“中国上市公司投资者关系管理天马奖”、中国证券报金牛奖“2024年度金牛上市公司分红回报奖”和“2024年度金牛最具价值投资奖”等荣誉。","listedPrice":13},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"九州通(600998)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供九州通(600998)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"九州通,600998,九州通股票,九州通股票老虎,九州通股票老虎国际,九州通行情,九州通股票行情,九州通股价,九州通股市,九州通股票价格,九州通股票交易,九州通股票购买,九州通股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"九州通(600998)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供九州通(600998)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}